TY - JOUR
T1 - Constitutive cell surface association between CD4 and CCR5
AU - Xiao, Xiaodong
AU - Wu, Lijun
AU - Stantchev, Tzanko S.
AU - Feng, Yan Ru
AU - Ugolini, Sophie
AU - Chen, Hong
AU - Shen, Zhimin
AU - Riley, James L.
AU - Broder, Christopher C.
AU - Sattentau, Quentin J.
AU - Dimitrov, Dimiter S.
PY - 1999/6/22
Y1 - 1999/6/22
N2 - HIV-1 entry into cells involves formation of a complex between gp120 of the viral envelope glycoprotein (Env), a receptor (CD4), and a coreceptor. For most strains of HIV, this coreceptor is CCR5. Here, we provide evidence that CD4 is specifically associated with CCR5 in the absence of gp120 or any other receptor-specific ligand. The amount of CD4 coimmunoprecipitated with CCR5 was significantly higher than that with the other major HIV coreceptor, CXCR4, and in contrast to CXCR4 the CD4-CCR5 coimmunoprecipitation was not significantly increased by gp120. The CD4-CCR5 interaction probably takes place via the second extracellular loop of CCR5 and the first two domains of CD4. It can be inhibited by CCR5- and CD4-specific antibodies that interfere with HIV-1 infection, indicating a possible role in virus entry. These findings suggest a possible pathway of HIV-1 evolution and development of immunopathogenicity, a potential new target for antiretroviral drugs and a tool for development of vaccines based on EnvCD4-CCR5 complexes. The constitutive association of a seven-transmembrane-domain G protein-coupled receptor with another receptor also indicates new possibilities for cross- talk between cell surface receptors.
AB - HIV-1 entry into cells involves formation of a complex between gp120 of the viral envelope glycoprotein (Env), a receptor (CD4), and a coreceptor. For most strains of HIV, this coreceptor is CCR5. Here, we provide evidence that CD4 is specifically associated with CCR5 in the absence of gp120 or any other receptor-specific ligand. The amount of CD4 coimmunoprecipitated with CCR5 was significantly higher than that with the other major HIV coreceptor, CXCR4, and in contrast to CXCR4 the CD4-CCR5 coimmunoprecipitation was not significantly increased by gp120. The CD4-CCR5 interaction probably takes place via the second extracellular loop of CCR5 and the first two domains of CD4. It can be inhibited by CCR5- and CD4-specific antibodies that interfere with HIV-1 infection, indicating a possible role in virus entry. These findings suggest a possible pathway of HIV-1 evolution and development of immunopathogenicity, a potential new target for antiretroviral drugs and a tool for development of vaccines based on EnvCD4-CCR5 complexes. The constitutive association of a seven-transmembrane-domain G protein-coupled receptor with another receptor also indicates new possibilities for cross- talk between cell surface receptors.
KW - AIDS
KW - HIV
KW - Receptors
UR - http://www.scopus.com/inward/record.url?scp=13044317266&partnerID=8YFLogxK
U2 - 10.1073/pnas.96.13.7496
DO - 10.1073/pnas.96.13.7496
M3 - Article
C2 - 10377443
AN - SCOPUS:13044317266
SN - 0027-8424
VL - 96
SP - 7496
EP - 7501
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 13
ER -